Dr. Fernando Martín Biscione

Dr. Fernando Martín Biscione

Unimed Belo Horizonte Head of Epidemiology, Brazil





2010  Ph.D., Minas Gerais Federal University, Brazil

2006  M.Sc., Minas Gerais Federal University, Brazil


Publications (Selected)

  1. Westin MR, Biscione FM, Ribeiro KM, Greco DB, Tupinambas U. Effectiveness at 48 Weeks of Switching from Enfuvirtide to Raltegravir in Virologically Suppressed Multidrug-Resistant HIV Type 1-Infected Patients in a Brazilian Cohort. AIDS Res Human Retroviruses 2013;30:113-117.
  2. Ribeiro KM, Biscione FM, Westin MR, Machado DP, Greco DB, Tupinambas U. Virologic and immunologic effectiveness of darunavir-based salvage therapy in HIV-1-infected adults in a Brazilian clinical practice setting: results of a multicenter and retrospective cohort study. Braz J Infect Dis 2013;18:1-7.
  3. Biscione FM, Westin MR, Ribeiro KM, Estevam DL, Cardoso SW, Tenore SB, Neto LF, Alencastro PR, Suffert TA, De Moraes MJ, Barbosa AN, Morejon KML, De Arruda EAG, Silveira JM, Neto JLA, Greco DB, Tupinambas U. Virologic and Immunologic Effectiveness at 48 Weeks of Darunavir-Ritonavir-Based Regimens in Treatment-Experienced Persons Living with HIV-1 Infection in Clinical Practice: A Multicenter Brazilian Cohort. J Int Assoc Provid AIDS Care 2013;13:63-68.
  4. Biscione FM, Couto RC, Pedrosa TM. Performance, Revision and Extension of the National Nosocomial Infections Surveillance System's Risk Index in Brazilian Hospitals. Infect Control Hosp Epidemiol 2012;33:124-134.
  5. Souza GF, Biscione FM, Greco DB, Rabello A. Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients. Rev Soc Bras Med Trop 2012;45:147-150.
  6. Westin MR, Biscione FM, Ordones M, Rodrigues M, Greco D, Tupinambas U. Resistance-associated mutation prevalence according to subtypes B and non-B of HIV-1 in antiretroviral-experienced patients in Minas Gerais, Brazil. AIDS Res Human Retroviruses 2011;27:981-987.
  7. Biscione FM, Couto RC, Pedrosa TM. In the search of alternative cut-off points for the variables of the National Nosocomial Infections Surveillance system’s surgical site infection risk index. Biostatistics, Bioinformatics and Biomathematics 2011;2(2):67-81.
  8. Biscione FM, Couto RC, Pedrosa TM. Accounting for incomplete postdischarge follow-up during surveillance of surgical site infection by use of the National Nosocomial Infections Surveillance system’s risk index. Infect Control Hosp Epidemiol 2009;30(5):433-439.
  9. Biscione FM. Rates of surgical site infection as a performance measure: are we ready? World J Gastrointest Surg 2009;1(1):11-15.
  10. Sales ML, Penna AP, Xavier JA, Biscione FM, Paes de Sousa RP, do Bem Filho PM, de Andrade Filho A, Lucas Jr. F. Description of a telemonitoring service for flu syndrome cases during the first wave of the Influenza A (H1N1v) pandemic at Unimed – Belo Horizonte (Brazil). Latin Am J Telehealth 2009;1(1):78-89.